JUL 11, 2015 4:21 PM PDT

Diabetes and Cognition

WRITTEN BY: Ilene Schneider
Harvard Medical School researchers believe that type 2 diabetes might reduce the ability to regulate blood flow, which, in turn, causes impaired cognitive and executive function. Over a period of 2 years, their ability to regulate blood flow decreases, as are the skill levels of participants with an average age of 66. Conversely, study participants with normal blood flow regulation have the ability to redistribute blood to areas that are more active during specific tasks, says an article published in Neurology and reported in Medical News Today (http://www.medicalnewstoday.com/articles/296584.php).
Can type 2 diabetes lead to dementia?
Study author Dr. Vera Novak, from Harvard Medical School, explains, "People with type 2 diabetes have impaired blood flow regulation. Our results suggest that diabetes and high blood sugar impose a chronic negative effect on cognitive and decision-making skills. Early detection and monitoring of blood flow regulation may be an important predictor of accelerated changes in cognitive and decision-making skills."

Wanting to investigate how inflammation, blood flow regulation in the brain and cognitive decline were related in people with the metabolic disorder, the researchers examined 40 people -- 19 with type 2 diabetes and 21 without it. The average age of the participants was 66. Participants who had type 2 diabetes had been treated for the disease for more than 5 years, receiving an average of 13 years of treatment. The researchers assessed participants' cognitive and memory functions while also measuring brain volume, blood flow and inflammation.

After 2 years, the researchers repeated the tests and discovered that the participants with type 2 diabetes experienced a reduction in their capacity to regulate the blood flow in their brains and performed worse in the cognitive and memory function tests. Average test scores fell by 12 percent, from 46 to 41, among those with type 2 diabetes, while the scores of those without diabetes remained steady at 55 points. Among the participants with type 2 diabetes, blood flow regulation fell by around 65 percent overall.

Other researchers have made the case for a link between type 2 diabetes and Alzheimer's disease, even going so far as calling Alzheimer's disease "type 3 diabetes." According to the Mayo Clinic, diabetes and Alzheimer's disease are connected in ways not completely understood. Studies indicate that people with diabetes, especially type 2 diabetes, are at higher risk of eventually developing Alzheimer's disease or other dementias and should take steps to prevent or control diabetes (http://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/diabetes-and-alzheimers/art-20046987).

Diabetes can cause several complications, such as damaging blood vessels, says the Mayo Clinic. Diabetes is considered a risk factor for vascular dementia, which occurs because of brain damage triggered reduced or blocked blood flow to the brain. It is also possible that Alzheimer's disease can be the result of the complex ways that type 2 diabetes affects the ability of the brain and other body tissues to use sugar (glucose) and respond to insulin.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
NOV 23, 2019
Drug Discovery & Development
NOV 23, 2019
Drug Seeks To Target Treatment-Resistant Epilepsy
Ever imagined a world where you cannot shower alone, drive by yourself, and even go to work in fear of having the next seizure that can incapacitate you? U...
NOV 25, 2019
Drug Discovery & Development
NOV 25, 2019
Discovery of mechanism behind Alexander disease may lead to enhanced drug development
Researchers have long known that the cause behind Alexander disease is a genetic culprit—mainly a mutation leading to the production of a defective p...
DEC 29, 2019
Cell & Molecular Biology
DEC 29, 2019
How close are we to a simple blood test for Parkinson's Disease?
Parkinson’s Disease (PD) alters nerve cells in the brain that produce the neurotransmitter dopamine. Famously regarded as the “happiness”...
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
JAN 28, 2020
Clinical & Molecular DX
JAN 28, 2020
Protein complex discovered as first biomarker of PTSD
  Researchers at the Centre for Addiction and Mental Health (CAMH) and the Canadian Institutes of Health Research (CIHR) have identified a potential d...
FEB 11, 2020
Neuroscience
FEB 11, 2020
The Gut: Your Second Brain
It turns out, "going with your gut" may be a more scientifically concrete phrase than we thought. The gut actually houses its own nervous system,...
Loading Comments...